Unitedhealth Group Inc (NYSE: UNH) on Friday, plunged -5.07% from the previous trading day, before settling in for the closing price of $578.97. Within the past 52 weeks, UNH’s price has moved between $436.38 and $630.73.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the growth rate of yearbook sales for the company of the Healthcare sector was 10.25%. The company achieved an average annual earnings per share of 9.90%. With a float of $918.14 million, this company’s outstanding shares have now reached $923.00 million.
Considering the fact that the conglomerate employs 440000 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 22.24%, operating margin of 8.24%, and the pretax margin is 5.15%.
Unitedhealth Group Inc (UNH) Insider Activity
Observing investor behavior towards Healthcare Plans industry stocks is more important than anything else. The insider ownership of Unitedhealth Group Inc is 0.23%, while institutional ownership is 89.62%. The most recent insider transaction that took place on Nov 11 ’24, was worth 438,987. In this transaction EVP & Chief People Officer of this company sold 701 shares at a rate of $626.23, taking the stock ownership to the 7,105 shares. Before that another transaction happened on Nov 11 ’24, when Company’s Officer proposed sale 701 for $626.23, making the entire transaction worth $438,987.
Unitedhealth Group Inc (UNH) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 9.90% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.00% during the next five years compared to 14.37% growth over the previous five years of trading.
Unitedhealth Group Inc (NYSE: UNH) Trading Performance Indicators
Unitedhealth Group Inc (UNH) is currently performing well based on its current performance indicators. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 1.22. Likewise, its price to free cash flow for the trailing twelve months is 36.67.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 15.39, a number that is poised to hit 6.73 in the next quarter and is forecasted to reach 29.91 in one year’s time.
Technical Analysis of Unitedhealth Group Inc (UNH)
Compared to the last year’s volume of 3.9 million, its volume of 5.76 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 27.37%. Additionally, its Average True Range was 16.51.
During the past 100 days, Unitedhealth Group Inc’s (UNH) raw stochastic average was set at 7.55%, which indicates a significant increase from 6.96% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 38.19% in the past 14 days, which was higher than the 26.74% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $586.29, while its 200-day Moving Average is $537.62. Nevertheless, the first resistance level for the watch stands at $573.10 in the near term. At $596.59, the stock is likely to face the second major resistance level. The third major resistance level sits at $611.07. If the price goes on to break the first support level at $535.14, it is likely to go to the next support level at $520.66. Should the price break the second support level, the third support level stands at $497.17.
Unitedhealth Group Inc (NYSE: UNH) Key Stats
Market capitalization of the company is 480.17 billion based on 920,284K outstanding shares. Right now, sales total 371,622 M and income totals 22,381 M. The company made 100,820 M in profit during its latest quarter, and 6,055 M in sales during its previous quarter.
